Interferon Therapy for 2 Years or Longer Reduces the Incidence of Hepatocarcinogenesis in Patients with Chronic Hepatitis C Viral Infection

Publisher： Karger

E-ISSN： 1423-0100|47|6|355-361

ISSN： 0300-5526

Source： Intervirology, Vol.47, Iss.6, 2004-11, pp. : 355-361

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interferon Therapy Improves the Irregular Regeneration of Hepatocytes in Liver in Patients with C-Viral Chronic Hepatitis and Liver Cirrhosis

By  

Intervirology, Vol. 50, Iss. 2, 2006-12 ,pp. : 138-149

Karger

Access to resources Recommend Favorite

Incidence of Depression in Patients with Chronic Hepatitis C Receiving Combination Therapy of Pegylated Interferon-Alpha and Ribavirin

By  

Psychotherapy and Psychosomatics, Vol. 83, Iss. 5, 2014-08 ,pp. : 308-309

Karger

Access to resources Recommend Favorite

Effect of the Dose and Duration of Interferon-Alpha Therapy on the Incidence of Hepatocellular Carcinoma in Noncirrhotic Patients with a Nonsustained Response to Interferon for Chronic Hepatitis C

By  

Oncology, Vol. 61, Iss. 2, 2001-08 ,pp. : 134-142

Karger

Access to resources Recommend Favorite

Interferon for Decreasing the Incidence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C

By  

Oncology, Vol. 62, Iss. 1, 2002-01 ,pp. : 87-93

Karger

Access to resources Recommend Favorite

Mutations in non-structural 5A and rapid viral response to pegylated interferon-α-2b plus ribavirin therapy are associated with therapeutic efficacy in patients with genotype 1b chronic hepatitis C

By                                                  

International Journal of Molecular Medicine, Vol. 30, Iss. 5, 2012-01 ,pp. : 1048-1052

Spandidos Publications

Access to resources Recommend Favorite